psoriasis

Documents about psoriasis

• IL-17 Role in Variants of Psoriasis#829474ClinicalTrials.gov
• TSO for Plaque Psoriasis#843629ClinicalTrials.gov
• Moderate to Severe Plaque Psoriasis With Scalp Involvement#864332ClinicalTrials.gov
• Videocapillaroscopy Assessment During Systemic Agent Therapy in Psoriasis#855386ClinicalTrials.gov
• Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis#916794ClinicalTrials.gov
• Study to Assess the Safety and Efficacy of Subcutaneously Injected Risankizumab in Adult Participants With Genital or Scalp Psoriasis#856833ClinicalTrials.gov
• Topical CP-690,550 For Chronic Plaque Psoriasis#825385ClinicalTrials.gov
• Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque Psoriasis#828739ClinicalTrials.gov
• Psoriasis Inflammation and Systemic Co Morbidities#18764ClinicalTrials.gov
• A Study to Evaluate the Safety and Efficacy of Adalimumab in Subjects With Chronic Plaque Psoriasis and Nail Psoriasis#859012ClinicalTrials.gov
• An Efficacy and Safety Study of CNTO1959 (Guselkumab) in the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis#830887ClinicalTrials.gov
• An Explorative Psoriasis Biomarker Study#810683ClinicalTrials.gov
• LEO 32731 for the Treatment of Moderate to Severe Psoriasis Vulgaris#910135ClinicalTrials.gov
• Exploratory Clinical Study on Fasting in Psoriasis and Psoriatic Arthritis (RiseFast)#898638ClinicalTrials.gov
• Glucose Trnsporter and PEDF in Psoriasis#152588ClinicalTrials.gov
• New Topical Treatment in Plaque Psoriasis#398277ClinicalTrials.gov
• The CorEvitas Psoriasis (PSO) Registry#879785ClinicalTrials.gov
• HPP737 in Adult Patients With Plaque Psoriasis#846231ClinicalTrials.gov
• A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)#830635ClinicalTrials.gov
• 308nm Excimer Laser for Treatment of Fingernail Psoriasis#901378ClinicalTrials.gov
• Efficacy of Topical Metformin in Psoriasis Vulgaris#407872ClinicalTrials.gov
• Therapeutic Education Program in Psoriasis#844822ClinicalTrials.gov
• LCD Solution Versus Calcipotriol Cream in the Treatment of Moderate Plaque Psoriasis#826149ClinicalTrials.gov
• Safety and Efficacy Study of a Novel Ointment to Treat Plaque Type Psoriasis#834622ClinicalTrials.gov
• A Phase I Study to Assess Novel Ointment in a Psoriasis Plaque Test#835792ClinicalTrials.gov
• ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.#857151ClinicalTrials.gov
• Study to Evaluate Psoriasis Severity and Its Psychosocial Impact Using the Simplified Psoriasis Index (SPI), as Well as Long-term Safety, Tolerability and Efficacy of Secukinumab Administered Subcutaneously in Patients With Moderate to Severe Psoriasis#968561ClinicalTrials.gov
• A Study to Evaluate Raptiva in Adults With Moderate to Severe Plaque Psoriasis Who Are Candidates for Systemic Therapy#995509ClinicalTrials.gov
• Botox Versus Tacrolimus in Psoriasis Vulgaris#841262ClinicalTrials.gov
• ProspectIve Cohort psoriASiS fOllow-up (PICASSO)#900636ClinicalTrials.gov
• A Study to Assess the Severity of Psoriasis in Brazilians Participants With Chronic Plaque-type Psoriasis#910381ClinicalTrials.gov
• Prevalence of Periodontitis in Patients With Plaque Psoriasis. A Cross-sectional Study#966832ClinicalTrials.gov
• A Study to Evaluate Effectiveness and Safety of Deucravacitinib in Participants With Non-Pustular Palmoplantar and Genital Psoriasis#992042ClinicalTrials.gov
• Immunogenetic Profiling of Goeckerman Therapy in the Treatment of Psoriasis Vulgaris#802485ClinicalTrials.gov
• Comparison of Otezla to SFA-002 to Placebo in Plaque Psoriasis Patients#806799ClinicalTrials.gov
• Study to Investigate Dose-related Efficacy of LAS41004 in the Treatment of Psoriasis#848799ClinicalTrials.gov
• A Psoriasis Plaque Test Comparing Eight Different Formulations of Vitamin D Analogues for the Treatment of Psoriasis#854957ClinicalTrials.gov
• Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients#856266ClinicalTrials.gov
• Clinical Study to Investigate Psorax35 Supplementation in Patients With Psoriasis#859790ClinicalTrials.gov
• Topical Thymoquinone in Psoriasis Vulgaris#905216ClinicalTrials.gov
• A Clinical Study of Increased Dose of TA-650 in Patients With Psoriasis#834226ClinicalTrials.gov
• International Rare And Severe Psoriasis Expert Network#873050ClinicalTrials.gov
• A Study to Provide Real-world Evidence on the Treatment Goal Achievement Rate, Adherence to and Utilization Patterns of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in Greece#834917ClinicalTrials.gov
• A Study to Evaluate IBI112 in the Treatment of Psoriasis With Moderate to Severe Plaque Psoriasis#888689ClinicalTrials.gov
• Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic Dermatitis#891815ClinicalTrials.gov
• Sensitivity and Specificity of QuantiFeron -TB Gold Test (QFT-G)in Patients With Psoriasis#827056ClinicalTrials.gov
• Use of Alternative Therapy in Psoriasis Vulgaris Patients#833381ClinicalTrials.gov
• Understanding Participation Habits Among Plaque Psoriasis Patients#840290ClinicalTrials.gov
• Spesolimab (BI 655130) Single Dose in Generalized Pustular Psoriasis#843129ClinicalTrials.gov
• Evaluation of TWEAK in Plaque Psoriasis and Psoriatic Arthritis Patients#888942ClinicalTrials.gov

Related topics